BTMPS is a compound that is widely used as a light stabilizer in many commonly encountered materials (e.g., coatings, paints,...
Aegis is excited to announce the launch of a groundbreaking data visualization dashboard designed to...
The focus of this clinical update is to evaluate changes observed in the prevalence of NPS detected at Aegis in...
NASHVILLE, TN. (December 10, 2024) – Aegis Sciences Corporation, a health care testing lab based in Nashville, TN, is pleased...
Ketamine is a noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist. It is FDA approved for the induction and maintenance of anesthesia.1 When used...
Gabapentin (Neurontin, Gralise, Horizant) was first approved by the US Food and Drug Administration (FDA) in 1993 for the treatment...
Sign up for the Aegis Newsletter